CD8A and neoplasm: This feasible and convenient approach significantly prevents tumor progression by reshaping the immunosuppressive tumor microenvironment with increased DCs, reduced Mo‐MDSC and TAMs infiltration, and enhanced antigen‐specific CD8+ T cell response in vivo.